Research brief: UCLA scientists detail the manufacturing and safety testing behind a gene-edited stem cell therapy now in a phase 1 clinical trial.
Need help?
Contact usResearch brief: UCLA scientists detail the manufacturing and safety testing behind a gene-edited stem cell therapy now in a phase 1 clinical trial.